Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 5/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30688690 | 0.78 | — | — | |
| SCHEMBL6933803 | 0.76 | ALDH1A1 (0.43) | ALDH1A1TP53CYP3A4MGLL | |
| SCHEMBL18729639 | 0.75 | ALDH1A1 (0.36) | ALDH1A1TP53CYP3A4 | |
| SCHEMBL377540 | 0.72 | ALDH1A1 (0.57) | ALDH1A1TP53CYP3A4MGLL | |
| SCHEMBL6432024 | 0.70 | ALDH1A1 (0.41) | ALDH1A1TP53CYP3A4MGLL | |
| SCHEMBL5185884 | 0.69 | — | — | |
| SCHEMBL16340361 | 0.68 | ALDH1A1 (0.53) | ALDH1A1TP53CYP3A4MGLL | |
| SCHEMBL6437013 | 0.68 | TP53 (0.46) | ALDH1A1TP53CYP3A4MGLL | |
| SCHEMBL14624754 | 0.68 | CA12 (0.37) | — | |
| SCHEMBL9578287 | 0.68 | CA12 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120029116-A1 | CURABLE ADHESIVE COMPOSITIONS, PROCESS, AND APPLICATIONS | TRILLION SCIENCE, INC. (US) | 2012-02-02 | — | — | US | disclosed |
| US-8084553-B2 | Curable adhesive compositions, process, and applications | TRILLION SCIENCE, INC. (US) | 2011-12-27 | — | — | US | disclosed |
| US-20090181165-A1 | Curable adhesive compositions, Process, and applications | TRILLION SCIENCE, INC. (US) | 2009-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029116-A1 | CURABLE ADHESIVE COMPOSITIONS, PROCESS, AND APPLICATIONS | RBX1, SUZ12, CDH1 | ALDH1A1 429/4885TP53 3443/4885CYP3A4 809/4885 |
| US-20090181165-A1 | Curable adhesive compositions, Process, and applications | RBX1, SUZ12, CDH1 | ALDH1A1 429/4885TP53 3443/4885CYP3A4 809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.